Abstract Treatment of tuberculosis (TB) involves the administration of anti-mycobacterial
drugs for several months. The emergence of drug-resistant strains of Mycobacterium …

Abstract Globally, 265,713,467 confirmed cases of SARS-CoV-2 (CoV-2), including
5,260,888 deaths, have been reported by the WHO. It is important to study the mechanism of …

BACKGROUND Observational and preclinical data suggest metformin may prevent severe
coronavirus disease 2019 (COVID-19) outcomes. PURPOSE We conducted a systematic …

Abstract Coronavirus disease 2019 (COVID-19) has been associated with various liver
injury cases worldwide. To date, the prevalence, mechanism, clinical manifestations …

This review article explores the potential of metformin, a medication commonly used for type
2 diabetes, as an antiviral and anti-inflammatory agent in the context of coronavirus disease …

Background & Aims Metabolic dysfunction-associated steatotic liver disease (MASLD)
results in steatosis, inflammation (steatohepatitis), and fibrosis. Patients with MASLD more …

The pesticide acetochlor (ACT) is a chiral isomer commonly detected in the global
environment, yet its specific impacts on liver function remain poorly understood. We utilized …

Background: COVID-19 has a major impact on cardiovascular diseases and may lead to
myocarditis or cardiac failure. The clove-like spike (S) protein of SARS-CoV-2 facilitates its …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes multi-organ
damage, which includes hepatic dysfunction, as observed in over 50% of COVID-19 …

The pandemic of 2019 coronavirus disease (COVID-19) has become a world public health
challenge. A new member of Coronaviridae family, named severe acute respiratory …